104 related articles for article (PubMed ID: 38720399)
1. Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas.
Ehret F; Perez E; Teichmann D; Meier S; Geiler C; Cosmas Z; Franke H; Roohani S; Wasilewksi D; Onken J; Vajkoczy P; Schweizer L; Kaul D; Capper D
Acta Neuropathol Commun; 2024 May; 12(1):74. PubMed ID: 38720399
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
[TBL] [Abstract][Full Text] [Related]
3. De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors.
Peyre M; Gauchotte G; Giry M; Froehlich S; Pallud J; Graillon T; Bielle F; Cazals-Hatem D; Varlet P; Figarella-Branger D; Loiseau H; Kalamarides M
Neuro Oncol; 2018 Jul; 20(8):1113-1121. PubMed ID: 29216385
[TBL] [Abstract][Full Text] [Related]
4. TERT Promoter Mutations and Risk of Recurrence in Meningioma.
Sahm F; Schrimpf D; Olar A; Koelsche C; Reuss D; Bissel J; Kratz A; Capper D; Schefzyk S; Hielscher T; Wang Q; Sulman EP; Adeberg S; Koch A; Okuducu AF; Brehmer S; Schittenhelm J; Becker A; Brokinkel B; Schmidt M; Ull T; Gousias K; Kessler AF; Lamszus K; Debus J; Mawrin C; Kim YJ; Simon M; Ketter R; Paulus W; Aldape KD; Herold-Mende C; von Deimling A
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26668184
[TBL] [Abstract][Full Text] [Related]
5. Molecular biological determinations of meningioma progression and recurrence.
Linsler S; Kraemer D; Driess C; Oertel J; Kammers K; Rahnenführer J; Ketter R; Urbschat S
PLoS One; 2014; 9(4):e94987. PubMed ID: 24722350
[TBL] [Abstract][Full Text] [Related]
6. A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.
Aizer AA; Abedalthagafi M; Bi WL; Horvath MC; Arvold ND; Al-Mefty O; Lee EQ; Nayak L; Rinne ML; Norden AD; Reardon DA; Wen PY; Ligon KL; Ligon AH; Beroukhim R; Dunn IF; Santagata S; Alexander BM
Neuro Oncol; 2016 Feb; 18(2):269-74. PubMed ID: 26323607
[TBL] [Abstract][Full Text] [Related]
7. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses.
Kishida Y; Natsume A; Kondo Y; Takeuchi I; An B; Okamoto Y; Shinjo K; Saito K; Ando H; Ohka F; Sekido Y; Wakabayashi T
Carcinogenesis; 2012 Feb; 33(2):436-41. PubMed ID: 22102699
[TBL] [Abstract][Full Text] [Related]
9. Pathodiagnostic parameters and evaluation of O⁶- methyl guanine methyl transferase gene promoter methylation in meningiomas.
Jabini R; Moradi A; Afsharnezhad S; Ayatollahi H; Behravan J; Raziee HR; Mosaffa F
Gene; 2014 Apr; 538(2):348-53. PubMed ID: 24398011
[TBL] [Abstract][Full Text] [Related]
10. TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.
Biczok A; Kraus T; Suchorska B; Terpolilli NA; Thorsteinsdottir J; Giese A; Tonn JC; Schichor C
J Neurooncol; 2018 Sep; 139(3):671-678. PubMed ID: 29808339
[TBL] [Abstract][Full Text] [Related]
11. TERT promoter mutations in primary and secondary WHO grade III meningioma.
Maier AD; Stenman A; Svahn F; Mirian C; Bartek J; Juhler M; Zedenius J; Broholm H; Mathiesen T
Brain Pathol; 2021 Jan; 31(1):61-69. PubMed ID: 32805769
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic changes underlie the aggressiveness of histologically benign meningiomas that recur.
San-Miguel T; Navarro L; Megías J; Muñoz-Hidalgo L; Gil-Benso R; Roldán P; López-Ginés C; Cerdá-Nicolás M
Hum Pathol; 2019 Feb; 84():105-114. PubMed ID: 30261191
[TBL] [Abstract][Full Text] [Related]
13. Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence.
Katz LM; Hielscher T; Liechty B; Silverman J; Zagzag D; Sen R; Wu P; Golfinos JG; Reuss D; Neidert MC; Wirsching HG; Baumgarten P; Herold-Mende C; Wick W; Harter PN; Weller M; von Deimling A; Snuderl M; Sen C; Sahm F
Acta Neuropathol; 2018 Jun; 135(6):955-963. PubMed ID: 29627952
[TBL] [Abstract][Full Text] [Related]
14. Genomic analysis of spinal meningiomas: correlation with histopathological grade.
Driver J; Santagata S; Bi WL; Chi JH
J Neurosurg Spine; 2023 Dec; 39(6):729-733. PubMed ID: 37728381
[TBL] [Abstract][Full Text] [Related]
15. DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.
Menghi F; Orzan FN; Eoli M; Farinotti M; Maderna E; Pisati F; Bianchessi D; Valletta L; Lodrini S; Galli G; Anghileri E; Pellegatta S; Pollo B; Finocchiaro G
Oncologist; 2011; 16(10):1440-50. PubMed ID: 21948653
[TBL] [Abstract][Full Text] [Related]
16. Genetic changes with prognostic value in histologically benign meningiomas.
Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C
Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303
[TBL] [Abstract][Full Text] [Related]
17. hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.
Fürtjes G; Köchling M; Peetz-Dienhart S; Wagner A; Heß K; Hasselblatt M; Senner V; Stummer W; Paulus W; Brokinkel B
J Neurooncol; 2016 Oct; 130(1):79-87. PubMed ID: 27465278
[TBL] [Abstract][Full Text] [Related]
18. The histopathological spectrum of human meningiomas.
Backer-Grøndahl T; Moen BH; Torp SH
Int J Clin Exp Pathol; 2012; 5(3):231-42. PubMed ID: 22558478
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation analysis of benign and atypical meningiomas: correlation between RUNX3 methylation and WHO grade.
Majchrzak-Celińska A; Paluszczak J; Szalata M; Barciszewska AM; Nowak S; Baer-Dubowska W
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1593-601. PubMed ID: 25648363
[TBL] [Abstract][Full Text] [Related]
20. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
